Skip to content

Clinical trials

Bacteremia trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bacteremia Country / region: Greece Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20142
20161
20171
20181
20191
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)2
Basilea Pharmaceutica1
ContraFect1
Entasis Therapeutics1
Hellenic Institute for the Study of Sepsis1
Infectopharm Arzneimittel GmbH1
National and Kapodistrian University of Athens1
UMC Utrecht1
University of Athens1
University of Thessaly1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bacteremia11
Sepsis4
Bacterial Infections2
Intraabdominal Infections2
Staphylococcal Infections2
Urinary Tract Infections2
Bone Diseases, Infectious1
Brain Abscess1
Central Nervous System Bacterial Infections1
Cholangitis1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.